Key result
Clerodendrum volubile extract mitigates doxorubicin-induced liver and kidney injury in rats.
Why the study?
Hepatorenal toxicity is a side effect of doxorubicin used in cancer treatment, and the potential protective effect of Clerodendrum volubile ethanol leaf extract was investigated.
Does Clerodendrum volubile ethanol leaf extract prevent doxorubicin-induced hepatorenal toxicities in male Wistar rats?
Does Clerodendrum volubile ethanol leaf extract prevent doxorubicin-induced hepatorenal toxicities in male Wistar rats?
Clerodendrum volubile ethanol leaf extract demonstrates protective effects against doxorubicin-induced hepatorenal toxicity in a rat model, likely mediated through suppression of oxidative stress.
Answers are grounded in this paper and cite their sources.
May protect against doxorubicin hepatorenal injury in rats; hypothesis-generating and should not change clinical practice.
Background and Purpose: Hepatorenal toxicity is a side effect of the anthracycline cytotoxic antibiotics, doxorubicin that is used in cancer treatment. The study investigated the ameliorative potential of Clerodendrum volubile ethanol leaf extract (CVE) on doxorubicin (DOX)-induced hepatorenal toxicities. Methods: Male Wistar rats were pretreated with Clerodendrum volubile ethanol leaf extract (50 - 400 mg/kg/day, p.o) followed by intraperitoneal injection of 2.5 mg/kg of DOX on alternate days for 14 days. Hepatorenal toxicity was assessed using renal function parameters (serum electrolytes, blood urea and creatinine), hepatic function endpoints [aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP), total protein (TP), albumin (ALB) and total bilirubin (TB)]. In addition, the antioxidant activity in the kidney and liver tissues were assayed and histological studies of these tissues were also conducted. Results: Oral pretreatment with 50 mg/kg/day, 100 mg/kg/day, 200 mg/kg/day and 400 mg/kg/day of CVE remarkably ameliorated DOX-induced liver and kidney injury by lowering the serum ALT, AST, ALP, Cr and BUN levels. CVE pretreatment remarkably ameliorated DOX-induced increases in the CAT, SOD and GPx activities and MDA levels compared to the DOX-treated rats. The biochemical changes were corroborated by improvements in the DOX-induced histological lesions seen in the hepatic and renal tissues examined. Conclusions: Overall, these findings suggest that Clerodendrum volubile ethanol leaf extract elicits protective effect against DOX-induced hepatorenal toxicities mediated primarily via oxidative stress suppression and improvement in the free radicals scavenging activities of CVE.
No takes yet. Share an insight, caveat, or question.
Adeneye et al. (2021) studied Doxorubicin-induced hepatorenal toxicities. Clerodendrum volubile ethanol leaf extract (CVE) vs. DOX-treated rats was evaluated on Hepatorenal toxicity (serum ALT, AST, ALP, Cr, BUN, CAT, SOD, GPx, MDA). Oral pretreatment with Clerodendrum volubile ethanol leaf extract ameliorated doxorubicin-induced liver and kidney injury in rats by lowering serum ALT, AST, ALP, Cr, and BUN levels.
Synapse has enriched 10 related papers. Consider them for comparative context: